Properties of an HIV 'vaccine'.
Wahren
B
B
Sandström
E
E
Wigzell
H
H
D002986:Clinical Trials as Topic; D015686:Gene Products, env / Q000276:immunology*; D015483:HIV Antibodies / Q000096:biosynthesis; D019302:HIV Envelope Protein gp160; D015658:HIV Infections / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D016233:Immunotherapy, Active; D011489:Protein Denaturation; D011498:Protein Precursors / Q000276:immunology*
D015686:Gene Products, env; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors